---
document_datetime: 2023-09-21 19:34:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/norvir-epar-all-authorised-presentations_en.pdf
document_name: norvir-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9671115
conversion_datetime: 2025-12-20 17:47:52.686171
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA EU           | Number   | (Invented) name   | Strength                   | Pharmaceutical Form   | Route of Administration Immediate Packaging   | Content (concentration)                | Pack size   |
|-----------------|----------|-------------------|----------------------------|-----------------------|-----------------------------------------------|----------------------------------------|-------------|
| EU/1/96/016/005 | Norvir   | 100 mg            | Film-coated tablet         | Oral use              | bottle (HDPE)                                 | 30 tablets                             |             |
| EU/1/96/016/006 | Norvir   | 100 mg            | Film-coated tablet         | Oral use              | bottle (HDPE)                                 | 60 tablets                             |             |
| EU/1/96/016/007 | Norvir   | 100 mg            | Film-coated tablet         | Oral use              | bottle (HDPE)                                 | 90 (3 x 30)                            | tablets     |
| EU/1/96/016/009 | Norvir   | 100 mg            | Powder for Oral Suspension | Oral use              | Sachet (PE/alu/PET)                           | 30 sachets + 2 syringes + 1 mixing cup |             |